Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
By F. Hirsch, M. Varella-Garcia, P. Bunn, Michael V. Di Maria, R. Veve, Roy M Bremmes, A. Baron, C. Zeng, W. Franklin. Journal of Clinical Oncology, 2003
1,479 citations recorded by the source corpus.
Subfields: Genetics, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/66284dbc839f4f0dec31a9a9e20dca005fcde435
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- Erlotinib in lung cancer - molecular and clinical predictors of outcome. (2005, neutral): “Stable disease 137 (42) 52 (42) 80 (45) 287 (39) Progression 55 (17) 14 (11) 21 (12) 152 (21)”
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction (2010, background): “The survival signature included the EGFR gene, a prominent gene contributing to prognosis variation in diverse solid tumor such as breast and colorectal cancer [27,28,29,30] (Table S6).”